{
    "nct_id": "NCT05093335",
    "official_title": "In-human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET",
    "inclusion_criteria": "Twenty patients with histologically proven treatment-naïve, therapy-refractory or relapsed blood cancers meeting the below criteria will be included:\n\n* Indolent B- or T-cell Non-Hodgkin lymphoma (including cutaneous lymphomas) or Non-Hodgkin lymphoma with variable FDG uptake and clinical course, such as mantle cell lymphoma; and measurable disease according to Lugano criteria\n\nor\n\n* Histiocytic neoplasms (Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD) and/or Rosai-Dorfman disease (RDD)\n* MGUS/SMM or MM according to IMWG definitions\n* Solid tumors, such as lung cancers, meningioma, adrenocortical neoplasms including cortisol-producing adenomas or high suspicion for tumor, such as in patients with Cushing's disease.\n* Age ≥18\n* Negative serum pregnancy test for female volunteers of childbearing age and potential (as defined by MSKCC Standards & Guidelines) from assays obtained <2 weeks prior to study enrollment/intervention; or negative urine pregnancy test performed on the day of intervention\n* MSKCC patients\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Breast-feeding\n* History of renal functional disorders (chronic kidney disease with eGFR<30)\n* Refusal or inability to tolerate the scanning procedure (e.g., due to claustrophobia)",
    "miscellaneous_criteria": ""
}